List of Tables
Table 1. Global Spironolactone Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Spironolactone Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Spironolactone Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Spironolactone Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Spironolactone Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Spironolactone Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Spironolactone Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Spironolactone Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Spironolactone Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Spironolactone Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Spironolactone Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Spironolactone Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Spironolactone Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Spironolactone Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Spironolactone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Spironolactone Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Spironolactone Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Spironolactone Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Spironolactone Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Spironolactone Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Spironolactone Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Spironolactone Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Spironolactone Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Spironolactone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Spironolactone Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Spironolactone Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Spironolactone Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Spironolactone Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Spironolactone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Spironolactone Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Spironolactone Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Spironolactone Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Spironolactone Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Spironolactone Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Spironolactone Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Spironolactone Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Spironolactone Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Spironolactone Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Spironolactone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Spironolactone Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Spironolactone Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Spironolactone Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Spironolactone Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Spironolactone Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Spironolactone Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Spironolactone Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Spironolactone Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Spironolactone Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Spironolactone Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Spironolactone Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Spironolactone Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Spironolactone Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Spironolactone Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Spironolactone Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Spironolactone Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Spironolactone Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Spironolactone Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Spironolactone Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Spironolactone Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Spironolactone Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Spironolactone Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Spironolactone Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Spironolactone Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Spironolactone Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Spironolactone Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Spironolactone Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Spironolactone Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Spironolactone Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Spironolactone Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Spironolactone Drugs Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Zydus Company Information
Table 81. Zydus Description and Business Overview
Table 82. Zydus Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Zydus Spironolactone Drugs Product
Table 84. Zydus Recent Developments/Updates
Table 85. Sun Pharmaceuticals Company Information
Table 86. Sun Pharmaceuticals Description and Business Overview
Table 87. Sun Pharmaceuticals Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sun Pharmaceuticals Spironolactone Drugs Product
Table 89. Sun Pharmaceuticals Recent Developments/Updates
Table 90. Amneal Pharmaceuticals Company Information
Table 91. Amneal Pharmaceuticals Description and Business Overview
Table 92. Amneal Pharmaceuticals Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Amneal Pharmaceuticals Spironolactone Drugs Product
Table 94. Amneal Pharmaceuticals Recent Developments/Updates
Table 95. Actavis Elizabeth Company Information
Table 96. Actavis Elizabeth Description and Business Overview
Table 97. Actavis Elizabeth Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Actavis Elizabeth Spironolactone Drugs Product
Table 99. Actavis Elizabeth Recent Developments/Updates
Table 100. Jubilant Generics Company Information
Table 101. Jubilant Generics Description and Business Overview
Table 102. Jubilant Generics Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Jubilant Generics Spironolactone Drugs Product
Table 104. Jubilant Generics Recent Developments/Updates
Table 105. Mylan Company Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Mylan Spironolactone Drugs Product
Table 109. Mylan Recent Developments/Updates
Table 110. CMP Pharma Company Information
Table 111. CMP Pharma Description and Business Overview
Table 112. CMP Pharma Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CMP Pharma Spironolactone Drugs Product
Table 114. CMP Pharma Recent Developments/Updates
Table 115. Sandoz Company Information
Table 116. Sandoz Description and Business Overview
Table 117. Sandoz Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Sandoz Spironolactone Drugs Product
Table 119. Sandoz Recent Developments/Updates
Table 120. RPG Life Sciences Company Information
Table 121. RPG Life Sciences Description and Business Overview
Table 122. RPG Life Sciences Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. RPG Life Sciences Spironolactone Drugs Product
Table 124. RPG Life Sciences Recent Developments/Updates
Table 125. Suzhou Homesun Pharmaceutical Company Information
Table 126. Suzhou Homesun Pharmaceutical Description and Business Overview
Table 127. Suzhou Homesun Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Suzhou Homesun Pharmaceutical Spironolactone Drugs Product
Table 129. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 130. Sinopharm Zhonglian Pharmaceutical Company Information
Table 131. Sinopharm Zhonglian Pharmaceutical Description and Business Overview
Table 132. Sinopharm Zhonglian Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Sinopharm Zhonglian Pharmaceutical Spironolactone Drugs Product
Table 134. Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
Table 135. Chongqing Kerui Pharmaceutical Company Information
Table 136. Chongqing Kerui Pharmaceutical Description and Business Overview
Table 137. Chongqing Kerui Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Chongqing Kerui Pharmaceutical Spironolactone Drugs Product
Table 139. Chongqing Kerui Pharmaceutical Recent Developments/Updates
Table 140. Hangzhou Minsheng Pharmaceutical Company Information
Table 141. Hangzhou Minsheng Pharmaceutical Description and Business Overview
Table 142. Hangzhou Minsheng Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Hangzhou Minsheng Pharmaceutical Spironolactone Drugs Product
Table 144. Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
Table 145. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
Table 146. Jiangsu Chia Tai Fenghai Pharmaceutical Description and Business Overview
Table 147. Jiangsu Chia Tai Fenghai Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Jiangsu Chia Tai Fenghai Pharmaceutical Spironolactone Drugs Product
Table 149. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments/Updates
Table 150. Jiangsu Changjiang Pharmaceutical Company Information
Table 151. Jiangsu Changjiang Pharmaceutical Description and Business Overview
Table 152. Jiangsu Changjiang Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Jiangsu Changjiang Pharmaceutical Spironolactone Drugs Product
Table 154. Jiangsu Changjiang Pharmaceutical Recent Developments/Updates
Table 155. Yatai Pharma Company Information
Table 156. Yatai Pharma Description and Business Overview
Table 157. Yatai Pharma Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Yatai Pharma Spironolactone Drugs Product
Table 159. Yatai Pharma Recent Developments/Updates
Table 160. Shanghai Xinyi Wanxiang pharmaceutical Company Information
Table 161. Shanghai Xinyi Wanxiang pharmaceutical Description and Business Overview
Table 162. Shanghai Xinyi Wanxiang pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Shanghai Xinyi Wanxiang pharmaceutical Spironolactone Drugs Product
Table 164. Shanghai Xinyi Wanxiang pharmaceutical Recent Developments/Updates
Table 165. Hainan Haishen Tongzhou Pharmaceutical Company Information
Table 166. Hainan Haishen Tongzhou Pharmaceutical Description and Business Overview
Table 167. Hainan Haishen Tongzhou Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Hainan Haishen Tongzhou Pharmaceutical Spironolactone Drugs Product
Table 169. Hainan Haishen Tongzhou Pharmaceutical Recent Developments/Updates
Table 170. Shanghai Hengshan Pharmaceutical Company Information
Table 171. Shanghai Hengshan Pharmaceutical Description and Business Overview
Table 172. Shanghai Hengshan Pharmaceutical Spironolactone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Shanghai Hengshan Pharmaceutical Spironolactone Drugs Product
Table 174. Shanghai Hengshan Pharmaceutical Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Spironolactone Drugs Distributors List
Table 178. Spironolactone Drugs Customers List
Table 179. Spironolactone Drugs Market Trends
Table 180. Spironolactone Drugs Market Drivers
Table 181. Spironolactone Drugs Market Challenges
Table 182. Spironolactone Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Spironolactone Drugs
Figure 2. Global Spironolactone Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Spironolactone Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Oral Suspension Product Picture
Figure 7. Others Product Picture
Figure 8. Global Spironolactone Drugs Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Spironolactone Drugs Market Share by Application: 2025 & 2032
Figure 10. Heart failure
Figure 11. Hypertension
Figure 12. Edema
Figure 13. Aldosteronism
Figure 14. Hirsutism
Figure 15. Others
Figure 16. Global Spironolactone Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Spironolactone Drugs Market Size (US$ Million), 2021–2032
Figure 18. Global Spironolactone Drugs Sales (K Units), 2021–2032
Figure 19. Global Spironolactone Drugs Average Price (US$/Unit), 2021–2032
Figure 20. Spironolactone Drugs Report Years Considered
Figure 21. Spironolactone Drugs Sales Share by Manufacturers in 2025
Figure 22. Global Spironolactone Drugs Revenue Share by Manufacturers in 2025
Figure 23. Top 5 and Top 10 Global Spironolactone Drugs Players: Market Share by Revenue in Spironolactone Drugs in 2025
Figure 24. Spironolactone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 25. Global Spironolactone Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 26. North America Spironolactone Drugs Sales Market Share by Country (2021–2032)
Figure 27. North America Spironolactone Drugs Revenue Market Share by Country (2021–2032)
Figure 28. United States Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Canada Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Europe Spironolactone Drugs Sales Market Share by Country (2021–2032)
Figure 31. Europe Spironolactone Drugs Revenue Market Share by Country (2021–2032)
Figure 32. Germany Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. France Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. U.K. Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Italy Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Russia Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Asia Pacific Spironolactone Drugs Sales Market Share by Region (2021–2032)
Figure 38. Asia Pacific Spironolactone Drugs Revenue Market Share by Region (2021–2032)
Figure 39. China Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Japan Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. South Korea Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. India Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Australia Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. China Taiwan Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Southeast Asia Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Latin America Spironolactone Drugs Sales Market Share by Country (2021–2032)
Figure 47. Latin America Spironolactone Drugs Revenue Market Share by Country (2021–2032)
Figure 48. Mexico Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Brazil Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Argentina Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Colombia Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Middle East and Africa Spironolactone Drugs Sales Market Share by Country (2021–2032)
Figure 53. Middle East and Africa Spironolactone Drugs Revenue Market Share by Country (2021–2032)
Figure 54. Turkey Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 55. Saudi Arabia Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. UAE Spironolactone Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Global Sales Market Share of Spironolactone Drugs by Type (2021–2032)
Figure 58. Global Revenue Market Share of Spironolactone Drugs by Type (2021–2032)
Figure 59. Global Spironolactone Drugs Price (US$/Unit) by Type (2021–2032)
Figure 60. Global Sales Market Share of Spironolactone Drugs by Application (2021–2032)
Figure 61. Global Revenue Market Share of Spironolactone Drugs by Application (2021–2032)
Figure 62. Global Spironolactone Drugs Price (US$/Unit) by Application (2021–2032)
Figure 63. Spironolactone Drugs Value Chain
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
